---
created: 2025-04-13
updated: 2025-04-13T10:53
id: P(z(8Q+O~w
specialty: pharmaco
specialty_id: 556
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::26-antimycobacterial-therapy
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::28-isoniazid
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::08-microbiology::20-antimycobacterials
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::05-antibiotics::23-isoniazid-(ripe)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::03-antimycobacterials::01-tuberculosis-drugs::zanki-extra
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^expn::bgnonessentials
  - source/ak-step1-v11::^other::^expn::uworld
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
Isoniazid can be given as a monotherapy for tuberculosis ONLY when there is a(n) **positive** PPD and a(n) **negative** chest x-ray

---

# Answer
aka these patients have NO evidence of clinical disease